Longitudinal brain imaging of five malignant glioma patients treated with bevacizumab using susceptibility-weighted magnetic resonance imaging at 7 T.
暂无分享,去创建一个
Daniela Prayer | Siegfried Trattnig | Adelheid Woehrer | Matthias Preusser | Claudia Kronnerwetter | Iris Nöbauer | C. Marosi | D. Prayer | M. Preusser | S. Trattnig | G. Grabner | A. Woehrer | Günther Grabner | Christine Marosi | C. Kronnerwetter | Katarzyna Elandt | I. Nöbauer | K. Elandt
[1] D. Noll,et al. Homodyne detection in magnetic resonance imaging. , 1991, IEEE transactions on medical imaging.
[2] Rakesh K. Jain,et al. Normalizing tumor vasculature with anti-angiogenic therapy: A new paradigm for combination therapy , 2001, Nature Medicine.
[3] B. Scheithauer,et al. The 2007 WHO classification of tumours of the central nervous system , 2007, Acta Neuropathologica.
[4] Bin Ai,et al. Susceptibility-weighted imaging in grading brain astrocytomas. , 2010, European journal of radiology.
[5] S. Trattnig,et al. High-field, high-resolution, susceptibility-weighted magnetic resonance imaging: improved image quality by addition of contrast agent and higher field strength in patients with brain tumors , 2007, Neuroradiology.
[6] Oliver Kraff,et al. Imaging of adult astrocytic brain tumours with 7 T MRI: preliminary results , 2010, European Radiology.
[7] Xiaojun Xu,et al. Age, gender, and hemispheric differences in iron deposition in the human brain: An in vivo MRI study , 2008, NeuroImage.
[8] P. Wen,et al. Bevacizumab for recurrent malignant gliomas , 2008, Neurology.
[9] Markus Barth,et al. Nonnvasive assessment of vascular architecture and function during modulated blood oxygenation using susceptibility weighted magnetic resonance imaging , 2005, Magnetic resonance in medicine.
[10] E. Haacke,et al. Imaging iron stores in the brain using magnetic resonance imaging. , 2005, Magnetic resonance imaging.
[11] L R Schad,et al. High-resolution MR venography of cerebral arteriovenous malformations. , 1999, Magnetic resonance imaging.
[12] G. Jahng,et al. Semiquantitative Assessment of Intratumoral Susceptibility Signals Using Non-Contrast-Enhanced High-Field High-Resolution Susceptibility-Weighted Imaging in Patients with Gliomas: Comparison with MR Perfusion Imaging , 2009, American Journal of Neuroradiology.
[13] E. Haacke,et al. High‐resolution BOLD venographic imaging: a window into brain function , 2001, NMR in biomedicine.
[14] Yu-Chung N. Cheng,et al. Susceptibility weighted imaging (SWI) , 2004, Zeitschrift fur medizinische Physik.
[15] Jaladhar Neelavalli,et al. Susceptibility‐weighted imaging to visualize blood products and improve tumor contrast in the study of brain masses , 2006, Journal of magnetic resonance imaging : JMRI.
[16] T. Mikkelsen,et al. Bevacizumab alone and in combination with irinotecan in recurrent glioblastoma. , 2009, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.
[17] J. Uhm. Updated Response Assessment Criteria for High-Grade Gliomas: Response Assessment in Neuro-Oncology Working Group , 2010 .
[18] W. Lin,et al. MR high-resolution blood oxygenation level-dependent venography of occult (low-flow) vascular lesions. , 1999, AJNR. American journal of neuroradiology.
[19] E. Dósa,et al. Correlation of MRI sequences to assess progressive glioblastoma multiforme treated with bevacizumab , 2011, Journal of Neuro-Oncology.
[20] R. Stupp,et al. Current concepts and management of glioblastoma , 2011, Annals of neurology.
[21] Jürgen R. Reichenbach,et al. Investigation of the influence of carbon dioxide concentrations on cerebral physiology by susceptibility-weighted magnetic resonance imaging (SWI) , 2008, NeuroImage.
[22] A. Gregory Sorensen,et al. Angiogenesis in brain tumours , 2007, Nature Reviews Neuroscience.
[23] Dietrich Haubenberger,et al. A population‐specific symmetric phase model to automatically analyze susceptibility‐weighted imaging (SWI) phase shifts and phase symmetry in the human brain , 2010, Journal of magnetic resonance imaging : JMRI.
[24] O. Abe,et al. Three-dimensional susceptibility-weighted imaging at 3 T using various image analysis methods in the estimation of grading intracranial gliomas. , 2010, Magnetic resonance imaging.
[25] F Barkhof,et al. MR venography of multiple sclerosis. , 2000, AJNR. American journal of neuroradiology.
[26] Jaco J. M. Zwanenburg,et al. Fluid attenuated inversion recovery (FLAIR) MRI at 7.0 Tesla: comparison with 1.5 and 3.0 Tesla , 2009, European Radiology.
[27] L. Deangelis,et al. Patterns of relapse and prognosis after bevacizumab failure in recurrent glioblastoma , 2009, Neurology.
[28] Caterina Mainero,et al. In vivo imaging of cortical pathology in multiple sclerosis using ultra-high field MRI , 2009, Neurology.
[29] Carlo Ciulla,et al. Establishing a baseline phase behavior in magnetic resonance imaging to determine normal vs. abnormal iron content in the brain , 2007, Journal of magnetic resonance imaging : JMRI.